References
Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003, 362:777–781.
Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948–1955.
Owan TE, Hodge DO, Herges RM, et al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251–259.
Bhatia RS, Tu JV, Lee DS, et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260–269.
Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004, 350:1953–1959.
Kitzman DW, Gardin JM, Gottdiener JS, et al.: Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001, 87:413–419.
Kitzman DW, Little WC, Brubaker PH, et al.: Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288:2144–2150.
Liao L, Jollis JG, Anstrom KJ, et al.: Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med 2006, 166:112–118.
Westermann D, Kasner M, Steendijk P, et al.: Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008, 117:2051–2060.
Kitzman DW, Higginbotham MB, Cobb FR, et al.: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065–1072.
Sciarretta S, Paneni F, Palano F, et al.: Role of the reninangiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Science (London) 2009, 116:467–477.
Cleland JG, Tendera M, Adamus J, et al.: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006, 27:2338–2345.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Forman, D., Gaziano, J.M. Irbesartan in patients with heart failure and preserved ejection fraction. Curr Cardio Risk Rep 3, 311–312 (2009). https://doi.org/10.1007/s12170-009-0056-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12170-009-0056-1